Subtyping depression using brain–gastric electrophysiology for early prediction of antidepressant response: a multicentric clinical study - Scorecard - MDSpire
Advertisement
Subtyping depression using brain–gastric electrophysiology for early prediction of antidepressant response: a multicentric clinical study
Clinical Scorecard: Classifying Depression through Brain-Gastric Electrophysiology for Early Antidepressant Response Prediction: A Multicenter Clinical Investigation
At a Glance
Category
Detail
Condition
Depression
Key Mechanisms
Electrophysiological markers from brain and gut interactions
Target Population
Adults with Major Depressive Disorder, including treatment-naive patients
Care Setting
Multicenter clinical investigation
Key Highlights
Approximately 50-60% of patients do not respond to first-line antidepressants.
Predictive models achieved 78% specificity and 84% sensitivity in identifying nonresponders.
Electrophysiological features can predict treatment outcomes for specific depression subtypes.
Combining brain and gut markers offers a scalable approach for personalized treatment.
Higher frontocentral theta power and beta asymmetry are predictive of treatment responses.
Guideline-Based Recommendations
Diagnosis
Utilize clinical assessments alongside electrophysiological markers for diagnosis.
Management
Incorporate predictive models to guide personalized antidepressant treatment strategies.
Monitoring & Follow-up
Assess treatment response within the first 4-6 weeks using identified biomarkers.
Risks
High rates of nonresponse and side effects associated with standard antidepressant treatments.
Patient & Prescribing Data
206 participants, including 144 treatment-naive patients.
Electrophysiological data can enhance prediction of antidepressant outcomes.
Clinical Best Practices
Combine brain and gut electrophysiological markers for treatment prediction.
Focus on phenotypic subtypes to tailor antidepressant therapy.
